Following a racist tweet issued by US comedienne Roseanne Barr earlier this week, Sanofi has rejected her claim that its sleep aid drug Ambien was responsible for her behaviour.
A look back at some of this week's most eyecatching stories, including the scandal around Cambridge Analytica's unauthorised data harvesting for the Trump election campaign.
The pharma industry is moving on from merely broadcasting on social platforms and starting to listen and engage, appreciating the benefits of mining these rich seams of data.